➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Harvard Business School
Dow
Johnson and Johnson
Merck

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

Nedocromil sodium - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for nedocromil sodium and what is the scope of freedom to operate?

Nedocromil sodium is the generic ingredient in three branded drugs marketed by King Pharms Llc, Allergan, Akorn, and Sanofi Aventis Us, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for nedocromil sodium. Two suppliers are listed for this compound.

Summary for nedocromil sodium
Recent Clinical Trials for nedocromil sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Childhood Asthma Research and Education NetworkPhase 3
Imperial College LondonPhase 2
National Heart, Lung, and Blood Institute (NHLBI)N/A

See all nedocromil sodium clinical trials

Pharmacology for nedocromil sodium
Medical Subject Heading (MeSH) Categories for nedocromil sodium

US Patents and Regulatory Information for nedocromil sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us TILADE nedocromil sodium SOLUTION;INHALATION 020750-001 Oct 1, 1997 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Akorn NEDOCROMIL SODIUM nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 090638-001 Aug 22, 2012 AT RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for nedocromil sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc TILADE nedocromil sodium AEROSOL, METERED;INHALATION 019660-001 Dec 30, 1992 ⤷  Try it Free ⤷  Try it Free
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Try it Free ⤷  Try it Free
Allergan ALOCRIL nedocromil sodium SOLUTION/DROPS;OPHTHALMIC 021009-001 Dec 8, 1999 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Harvard Business School
Dow
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.